Related Experiment Video
Updated: Jun 18, 2026
07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
[p53 and p27 gene expression in subserosal gallbladder carcinoma].
Iván Roa E1, Soledad Lantadilla H, Gilda Ibacache S
1Servicio de Anatomía Patológica, Clínica Alemana de Santiago, Chile. iroa@alemana.cl
Revista Medica De Chile
|November 17, 2009
Summary
p53 gene expression is a significant prognostic factor in subserosal gallbladder cancer, impacting patient survival rates. This finding aids in evaluating prognosis for this challenging cancer stage.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Context:
- Subserosal gallbladder carcinoma presents diagnostic and prognostic challenges.
- Early detection and accurate staging are critical for patient outcomes.
Purpose:
- To investigate the expression of p53 and p27 genes in subserosal gallbladder cancer.
- To determine the prognostic significance of p53 and p27 in this specific cancer subtype.
Summary:
- p53 and p27 gene expression were analyzed in 127 subserosal gallbladder cancer samples using immunohistochemistry.
- Fifty-six percent of tumors showed p53 positivity, and 46% showed p27 positivity.
- p53 expression was significantly associated with overall survival (p=0.05), while p27 expression was not.
Impact:
- p53 gene expression serves as a valuable prognostic biomarker for subserosal gallbladder cancer.
- This research contributes to improved prognostic evaluation and potential therapeutic strategies.
- Findings may guide clinical decision-making for patients with subserosal gallbladder cancer.
